We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 26, 2022

Impact of HbA1c on the Development of Severe Retinopathy and Nephropathy in Type 1 Diabetes

Diabetes Care


Additional Info

Diabetes Care
Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study
Diabetes Care 2022 Sep 12;[EPub Ahead of Print], HJ Arnqvist, MC Westerlund, M Fredrikson, J Ludvigsson, M Nordwall

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading